Back
Nimesh Pinnamaneni
ย โขย
Helixworks Technologiesย โขย 4m
Yupโspeed matters in diagnostics! ๐ Iโm working on building an automated infectious disease diagnostics lab. The goal is to take sequencing-based diagnostics mainstream.
Replies (1)
More like this
Recommendations from Medial
Nimesh Pinnamaneni
ย โขย
Helixworks Technologiesย โขย 4m
Looking to connect with folks in clinical diagnostics and molecular biology! Iโm building a new clinical lab focused on infectious disease diagnostics powered by DNA sequencing โ and would love to connect with people who have experience in: โข Runni
See More
Nimesh Pinnamaneni
ย โขย
Helixworks Technologiesย โขย 4m
Can Sequencing replace traditional diagnostics in India? Traditional diagnostics are slow. Culture and antibiotic resistance tests take days or even weeks to deliver results. This can be detrimental for patients suffering from sepsis or fever of unk
See More
Chirotpal Das
Building an AI eco-s...ย โขย 6m
๐กย Did you know India๐ฎ๐ณ is leading a ๐ ๐๐ง๐จ๐ฆ๐ข๐ ๐ซ๐๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง? Theย ๐๐๐ง๐จ๐ฆ๐๐๐ง๐๐ข๐ ๐๐ซ๐จ๐ฃ๐๐๐ญย is leading the way for a genomic revolution. What this means? โ ย ๐๐๐ซ๐ฌ๐จ๐ง๐๐ฅ๐ข๐ณ๐๐ ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐: By developing aย ๐ซ
See MoreNimesh Pinnamaneni
ย โขย
Helixworks Technologiesย โขย 4m
Why qPCR & Phenotypic Testing Must Be Displaced? โ Part III This is the third part of a deep dive into why qPCR & phenotypic testing need to be replaced. In Part I, I covered the limitations of current diagnostics & why incremental improvements aren
See More
Harshajit Sarmah
Founder & Editor of ...ย โขย 5m
After selling his bootstrapped startup Wingify for $200 million, Paras Chopra is diving into artificial intelligence. His next big project is a foundational AI research lab in India, focused on building advanced models and algorithms for the world.
See More
Anonymous
Hey I am on Medialย โขย 5m
BharatMed AI will be an AI-driven healthcare platform focused on early disease detection and prevention in India. Using multimodal AI, it will analyze genetics, medical imaging, wearables, and environmental factors to predict risks for diseases like
See MoreNimesh Pinnamaneni
ย โขย
Helixworks Technologiesย โขย 4m
Why qPCR & Phenotypic Testing Must Be Displaced โ Part II If you ever want to understand the scale of a problem, look at how much it costs. Tuberculosis alone costs India, Africa, and Brazil 27 trillion INR a year in lost productivity and healthcare
See More
Chandril Mallick
Hey I am on Medialย โขย 9m
๐ Seeking Funding for Innovative Health Tech Startup Iโm excited to share that Iโm working on a groundbreaking health tech startup, currently at the idea stage. We aim to revolutionize patient care, diagnostics, telemedicine.. Our goal is improve
See More
Sandeep Prasad
Business Coachย โขย 1m
๐ฐ ๐จ Big Pharma Meets Big AI: AstraZeneca Signs AI-Powered Research Deal in China! ๐จ๐ณ๐ง ๐ In a move that could reshape chronic disease treatment, pharma giant AstraZeneca has teamed up with Chinaโs CSPC Pharmaceutical Group to supercharge medical
See More
Nimesh Pinnamaneni
ย โขย
Helixworks Technologiesย โขย 4m
From โน51 Cr to โน1,272 Cr in a yearโthis Indian biotechโs revenue chart is insane. ๐ฐ Molbio is going public targeting โน22,000โ24,000 Cr valuation. IPO expected in November 2025, raising โน2,200โ2,400 Cr. ๐ฌ Their Truenat platform, is a battery-power
See More
Download the medial app to read full posts, comements and news.